Australian clinical-stage biotech Noxopharm (ASX:NOX) has announced a new research collaboration with UNSW Sydney, supported by a TechVoucher grant from the NSW Government, to explore the use of its Sofra technology in reducing inflammation caused by medical implants. …
Noxopharm and UNSW collaborate on gene-based approach to reducing implant inflammation
November 11, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
There is an ideology behind our funding systems, and it's the greatest barrier to change
March 11, 2026 - - Latest News -
New patient-led tool launched in Canberra to transform pain communication
March 10, 2026 - - Latest News -
Leader appointed to drive landmark Sydney biomedical hub toward global health breakthroughs
March 10, 2026 - -
New digital partnership expands access to clinical guidance for Australian healthcare professionals
March 10, 2026 - - Latest News -
Self injection option offers new flexibility for Australians living with Myasthenia Gravis
March 10, 2026 - - Latest News -
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - - Latest News -
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - - Latest News